Inventor · disambiguated record
Gesine Kerstin Veits
Also filed as: VEITS GESINE KERSTIN
7 granted patents·10 pending applications·54 citations·filing 2018–2025
81Inventor score
Top patents by PatentIndex Score
17 records- 0196US10849982B2C3-carbon linked glutarimide degronimers for target protein degradationC4 THERAPEUTICS INC·Filed 2018·Granted Dec 1, 2020·43 cites·17 claims
- 0293US11992531B2C3-carbon linked glutarimide degronimers for target protein degradationC4 THERAPEUTICS INC·Filed 2020·Granted May 28, 2024·3 cites·31 claims
- 0393US11691972B2Compounds for targeted degradation of BRD9C4 THERAPEUTICS INC·Filed 2021·Granted Jul 4, 2023·5 cites·10 claims
- 0489US12157735B2Compounds for targeted degradation of BRD9C4 THERAPEUTICS INC·Filed 2022·Granted Dec 3, 2024·1 cites·23 claims
- 0588US12049464B2Compounds for targeted degradation of BRD9C4 THERAPEUTICS INC·Filed 2022·Granted Jul 30, 2024·1 cites·11 claims
- 0681US11753397B2Cereblon binders for the degradation of ikarosC4 THERAPEUTICS INC·Filed 2020·Granted Sep 12, 2023·1 cites·19 claims
- 0781US2025084081A1Compounds for targeted degradation of brd9C4 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0879US12421220B2Bicyclic-substituted glutarimide cereblon bindersC4 THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·0 cites·26 claims
- 0979US2025382285A1Bicyclic-substituted glutarimide cereblon bindersC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1079US2025368631A1Bicyclic-substituted glutarimide cereblon bindersC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1170US2024199581A1Therapeutics for the degradation of mutant brafC4 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1259US2024245677A1Selected compounds for targeted degradation of brd9C4 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1358US2024424111A1Degrader Compounds and Uses ThereofCALICO LIFE SCIENCES LLC·Filed 2022·Application pending·0 cites
- 1458US2025302815A1Protein tyrosine phosphatase targeting ligandsCALICO LIFE SCIENCES LLC·Filed 2022·Application pending·0 cites
- 1556US2023233692A1Compounds for targeted degradation of retC4 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1651US2024383886A1Protein Tyrosine Phosphatase Degraders and Methods of Use ThereofCALICO LIFE SCIENCES LLC·Filed 2020·Application pending·0 cites
- 1750US2021198256A1Compounds for the degradation of brd9 or mth1C4 THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gesine Kerstin Veits files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →